Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02XNT
|
|||
Former ID |
DIB004006
|
|||
Drug Name |
BMS-A
|
|||
Synonyms |
CCR2 antagonists (inflammatory/metabolic diseases); CCR2 antagonists (inflammatory/metabolic diseases), Bristol-Myers Squibb
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Inflammation [ICD-11: 1A00-CA43.1] | Investigative | [1] | |
Company |
Bristol-Myers Squibb Co
|
|||
Structure |
Download2D MOL |
|||
Formula |
C16H10ClF3N2O3
|
|||
Canonical SMILES |
C1=CC(=CC=C1C2=NN(C(=O)O2)CC3=C(C=CC(=C3)Cl)O)C(F)(F)F
|
|||
InChI |
1S/C16H10ClF3N2O3/c17-12-5-6-13(23)10(7-12)8-22-15(24)25-14(21-22)9-1-3-11(4-2-9)16(18,19)20/h1-7,23H,8H2
|
|||
InChIKey |
QKOWACXSXTXRKA-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 202821-81-6
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:93672
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | C-C chemokine receptor type 2 (CCR2) | Target Info | Antagonist | [1] |
KEGG Pathway | Cytokine-cytokine receptor interaction | |||
Chemokine signaling pathway | ||||
NetPath Pathway | TCR Signaling Pathway | |||
IL2 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | ||||
Leptin Signaling Pathway | ||||
RANKL Signaling Pathway | ||||
Panther Pathway | Inflammation mediated by chemokine and cytokine signaling pathway | |||
Reactome | Beta defensins | |||
Chemokine receptors bind chemokines | ||||
G alpha (i) signalling events | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | |||
Defensins | ||||
Spinal Cord Injury | ||||
Peptide GPCRs | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 59). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.